{
  "id": 7538420,
  "title": "GSK strikes deal for Chimagen’s T cell engager for blood cancer",
  "url": "https://urgent.news/2026/09/15/gsk-strikes-deal-for-chimagens-t-cell-engager-for-blood-cancer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-15T11:03:57.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/gsk-strikes-deal-for-chimagens-t-cell-engager-for-blood-cancer/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Two years after GSK announced its first licensing deal with Chimagen Biosciences, the UK drugmaker is making a new deal with the Chinese company for a trispecific T cell engager that it ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}